M. Mayorga

Can vaccine prioritization reduce disparities in COVID-19 burden for historically marginalized populations?

Julie S. Ivy, J. Swann, P. Keskinocak, 2021, medRxiv.

Use of Modeling to Inform Decision Making in North Carolina during the COVID-19 Pandemic: A Qualitative Study

Julie S. Ivy, J. Swann, P. Delamater, 2022, MDM policy & practice.

Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study

J. De La Torre, M. Mayorga, C. González-Domenech, 2018, Journal of the International Association of Providers of AIDS Care.

Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART

J. Olalla, M. Mayorga, C. González-Domenech, 2016, European Journal of Clinical Microbiology & Infectious Diseases.

Emergence as an outbreak of the HIV-1 CRF19_cpx variant in treatment-naïve patients in southern Spain

A. Del Arco, J. De La Torre, L. Delaye, 2018, PloS one.

Mask Interventions in K12 Schools Can Also Reduce Community Transmission in Fall 2021

J. Swann, J. Ivy, Jessica Mele, 2021, medRxiv.

Vaccinating Children Against COVID-19 is Essential Prior to the Removal of Non-Pharmaceutical Interventions

Julie S. Ivy, J. Swann, P. Delamater, 2021, medRxiv.

COVID-19 Projections for K12 Schools in Fall 2021: Significant Transmission without Interventions

J. Swann, P. Keskinocak, J. Ivy, 2021, medRxiv.

Organizational decision‐making during COVID‐19: A qualitative analysis of the organizational decision‐making system in the United States during COVID‐19

Julie S. Ivy, J. Swann, P. Delamater, 2022, Journal of Contingencies and Crisis Management.